A solid-phase approach towards the synthesis of PDE5 inhibitors

被引:13
|
作者
Beer, D [1 ]
Bhalay, G [1 ]
Dunstan, A [1 ]
Glen, A [1 ]
Haberthuer, S [1 ]
Moser, H [1 ]
机构
[1] Novartis Horsham Res Ctr, Horsham RH12 5AB, W Sussex, England
关键词
D O I
10.1016/S0960-894X(02)00296-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
PDE5 inhibitors based upon the xanthine scaffold 8 have been expediently synthesized using a solid-phase route. Attachment of the xanthine scaffold 8 using the Rink chloride linker 4 and N-1 functionalization using Mitsunobu chemistry is described. A library of compounds was produced in multi-milligram quantities with excellent purities and acceptable yields. The compounds were tested for their PDE5 inhibitory activity. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1973 / 1976
页数:4
相关论文
共 50 条
  • [41] Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED
    Boyle, CD
    Xu, R
    Asberom, T
    Chackalamannil, S
    Clader, JW
    Greenlee, WJ
    Guzik, H
    Hu, YQ
    Hu, ZY
    Lankin, CM
    Pissarnitski, DA
    Stamford, AW
    Wang, YG
    Skell, J
    Kurowski, S
    Vemulapalli, S
    Palamanda, J
    Chintala, M
    Wu, P
    Myers, J
    Wang, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2365 - 2369
  • [42] PDE5 inhibitors: targeting erectile dysfunction in diabetics
    Francis, Sharron H.
    Corbin, Jackie D.
    CURRENT OPINION IN PHARMACOLOGY, 2011, 11 (06) : 683 - 688
  • [44] Can PDE5 inhibitors boost brain function?
    Melanie Clyne
    Nature Reviews Urology, 2014, 11 (2) : 65 - 65
  • [45] THERAPEUTIC USES OF PDE5 INHIBITORS WHAT IS THE FUTURE?
    Tsujimura, Akira
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 70 - 70
  • [46] PDE5 Inhibitors in Non-Urological Conditions
    Vlachopoulos, C.
    Terentes-Printzios, D.
    Ioakeimidis, N.
    Rokkas, K.
    Stefanadis, C.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (30) : 3521 - 3539
  • [47] PDE5 inhibitors and satisfaction of patients with erectile dysfunction
    Cour, F.
    PROGRES EN UROLOGIE, 2008, 18 (08): : 542 - 542
  • [48] The discovery of novel, potent and selective PDE5 inhibitors
    Bi, YZ
    Stoy, P
    Adam, L
    He, B
    Krupinski, J
    Normandin, D
    Pongrac, R
    Seliger, L
    Watson, A
    Macor, JE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) : 2461 - 2464
  • [49] The Effect of PDE5 Inhibitors on the Male Reproductive Tract
    Sofikitis, Nikolaos
    Kaltsas, Aris
    Dimitriadis, Fotios
    Rassweiler, Jens
    Grivas, Nikolaos
    Zachariou, Athanasios
    Kaponis, Apostolos
    Tsounapi, Panagiota
    Paterakis, Napoleon
    Karagiannis, Andreas
    Skouros, Sotirios
    Giannakis, Ioannis
    Champilomatis, Ioannis
    Paschopoulos, Minas
    Daphnis, Diamantis
    Giakoumakis, Ioannis
    R.Gabales, Melinda
    Chua, Jo Ben M.
    Lantin, Pedro L. Lantin, III
    Mamoulakis, Charalampos
    Takenaka, Atsushi
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (23) : 2697 - 2713
  • [50] PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile
    Kouvelas, D.
    Goulas, A.
    Papazisis, G.
    Sardeli, C.
    Pourzitaki, C.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (30) : 3464 - 3475